Congressional briefing raises concerns about new GMO crops with 2,4-D herbicide resistance

The next argument over genetically engineered crops has arrived with Dow AgroScience’s bid to gain federal approval for soybean and corn varieties that resist the herbicide 2,4-D and for Enlist Duo, a 2,4-D-glyphosate mix that can be used on the new varieties.

The double-headed proposal has angered opponents of biotech crops, who say it’s the second coming of “Roundup Ready.”

U.S. Rep. Peter DeFazio, D-Ore., convened a congressional briefing on the topic May 21 and, in a prepared statement, said food manufacturers and chemical companies are “running a dangerous experiment with the food we eat.”

He said chemical companies got farmers “hooked” on their earlier products and now want to do the same with 2,4-D. David Mortensen, a Pennsylvania State University weed scientist who took part in DeFazio’s briefing, said the applications could result in a huge increase in 2,4-D use across a broad swath of America’s cropland.

“This is not a minor tweak in our agriculture system,” Mortensen said. “There are downsides when you use pesticides like this.”

Iowa farmer George Naylor, who also took part in the briefing, said 2,4-D use should not become a routine practice. Naylor, who grows non-GMO corn and soybeans, said he’s used 2,4-D twice in 38 years of farming. The herbicide should be used only as a last resort, “rescue” application against weeds, he said.

Read the full, original article: Biotech critics oppose 2,4-D resistant crops

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The Orange Bowl without oranges: Can CRISPR save Florida citrus?
ChatGPT-Image-May-22-2026-10_26_09-AM
Gutting the National Science Board: How the Trump-RFK, Jr. crusade is erasing the separation of science and state
Screenshot-2026-04-14-at-11.11.06-AM
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Screenshot 2025-11-12 at 3.28
GLP podcast: Evolutionary biologist debunks the 'sex spectrum'
ChatGPT-Image-May-26-2026-09_19_32-AM
Viewpoint— “A safe space to chat, flirt, and be intimate without sex”: Are new AI companies exploiting vulnerable asexuals?
Screenshot 2026-05-22 at 3.28
Vagus nerve wellness grift: How to build a billion dollar business. Are you listening, Kelly Ripa?
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-May-26-2026-09_04_31-AM-2
Hantavirus revives COVID-era conspiracies and distrust in public health 
Screenshot 2026-05-22 at 11.31
‘Realistic and durable’: EPA proposes loosening restrictions on some PFAS ‘forever chemicals.’
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.